IKZF1plus is a frequent biomarker of adverse prognosis in Mexican pediatric patients with B-acute lymphoblastic leukemia. - Garcia-Solorio J; Núñez-Enriquez JC; Jiménez-Olivares M; Flores-Lujano J; Flores-Espino F; Molina-Garay C; Cervera A; Casique-Aguirre D; Peñaloza-Gonzalez JG; Baños-Lara MDR; García-Soto Á; Galván-Díaz CA; et al. (Frontiers in oncology, 2024)